- NICE issues conditional recommendation for digitally enabled therapies to treat depression and anxiety in adults
- Fimea launches pilot procedure for the evaluation of new hospital-only drugs
- The German Pharmaceutical association insists benefits must continue for Orphan drugs
- Promotion of RWE evidence in the approval process by the German G-BA and the Belgian KCE